Factors predicting lapatinib efficacy in HER-2+ metastatic breast carcinoma: Does it work better in different histologic subtypes?

Autor: S. S., Göksu1 semasezgingoksu@gmail.com, H., Bozcuk2, L., Koral3, B., Çakar4, S., Gündüz2, A. M., Tatli2, D., Arslan2, M., Uysal2, M., Koçer5, M., Artaç3, B., Karabulut4, H. S., Coskun1, M., Özdogan1, B., Savas1, Göksu, S S6 (AUTHOR), Bozcuk, H (AUTHOR), Koral, L (AUTHOR), Çakar, B (AUTHOR), Gündüz, S (AUTHOR), Tatlı, A M (AUTHOR)
Zdroj: Indian Journal of Cancer. Oct-Dec2015, Vol. 52 Issue 4, p517-519. 3p.
Databáze: Academic Search Ultimate